Nomura T, Maeda M, Kumazawa D, Mizuno Y, Onodera K, Toyoda S, Yamashita K. The effect of ablation settings on lesion characteristics with DiamondTemp ablation system: An ex vivo experiment. J Arrhythm 2024; 40(1): 109-117.

Abe S, Nishino S, Kanaya T, Sakuma M, Toyoda S. Low-density lipoprotein cholesterol-lowering therapy for atherosclerotic cardiovascular disease in the future. Am J Cardiol 2024; 215: 94-95.

Toyoda S. Blood pressure lowering effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA). Hypertens Res 2024; 47(3):803-804.

Nakajima Ta, Fukuda T, Shibasaki I, Obi S, Sakuma M, Abe S, Fukuda H, Toyoda S, Nakajima To. Pathophysiological roles of the serum acylcarnitine level and acylcarnitine/free carnitine ratio in patients with cardiovascular diseases. Int J Cardiol Heart Vasc 2024; 51: 101386.

Nakajima To, Haruyama A, Fukuda T, Minami K, Hirose S, Yazawa H, Nakajima Ta, Hasegawa T, Kitagawa Y, Obi S, Inami S, Oguri G, Shibasaki I, Amano H, Arikawa T, Sakuma M, Abe S, Fukuda H, Toyoda S. Left atrial reservoir strain is a marker of atrial fibrotic remodeling in patients undergoing cardiovascular surgery: Analysis of gene expression. PLoS One 2024; 19(7): e0306323.

Nomura T, Isawa T, Toyoda S, Yamashita K, Honda T. Transvenous extraction and reimplantation procedures for quadripolar left ventricular leads with an active fixation side helix. J Arrhythm 2024; 40(5): 1206-1209.

Toyoda S, Sakuma M, Ishida K, Kushida Y, Soma R, Takayama H, Akimoto K, Dezawa M, Inoue T. Accumulation of endogenous Muse cells in the myocardium and its pathophysiological role in patients with fulminant myocarditis. Clin Transl Sci 2024; 17(11): e70067.

Isawa T, Nomura T, Honda T, Yamaya K, Toyoda S. Apixaban, a possible treatment option for a "Ghost" left behind after transvenous lead extraction. Can J Cardiol 2024; 40(11): 2154-2155.